Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

August 24, 2017

Primary Completion Date

August 30, 2019

Study Completion Date

August 19, 2020

Conditions
Sentinel Lymph NodeBreast Cancer
Interventions
DRUG

Methylene Blue

Subcutaneous injection of injection point at the periphery of the areola or tumor, injecting 1% methylene blue 0.5ml at each point, a total of 2-3 points.

DRUG

Indocyanine Green

Within 5 minutes after MB injection, 2.5mg/ml ICG 0.5ml was injected at each point, a total of 2-3 points. Methylene blue and ICG injection points do not coincide

Trial Locations (1)

100190

Key Laboratory of Molecular Imaging, Chinese Academy of Sciences, Beijing

Sponsors
All Listed Sponsors
collaborator

Beijing Digital Precesion Medicine Company

UNKNOWN

collaborator

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER

collaborator

Beijing Friendship Hospital

OTHER

collaborator

Tangshan People's Hospital

OTHER

collaborator

The Second Hospital of Hebei Medical University

OTHER

lead

Chinese Academy of Sciences

OTHER_GOV

NCT03579979 - Sentinel Lymph Node Biopsy in Breast Cancer Surgery Using ICG | Biotech Hunter | Biotech Hunter